Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
14 mai 2024 16h15 HE
|
Lumos Pharma, Inc.
Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials Continue to Show Oral LUM-201...
Broadwind Announces First Quarter 2024 Results
14 mai 2024 07h00 HE
|
Broadwind, Inc.
CICERO, Ill., May 14, 2024 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today...
Bitfarms Reschedules First Quarter Conference Call to May 15th at 8:00am ET
13 mai 2024 07h00 HE
|
Bitfarms Ltd.
TORONTO and BROSSARD, Québec, May 13, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global vertically integrated Bitcoin mining company, announces that it will report first...
Caledonia Mining Corporation Plc Results for the Quarter ended March 31, 2024; Notice of Management Conference Call
13 mai 2024 02h00 HE
|
Caledonia Mining Corporation Plc
ST HELIER, Jersey, May 13, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or "the Company") (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces its operating and financial...
KULR Technology Group Sets First Quarter 2024 Earnings Call for Wednesday, May 15, 2024 at 4:30 p.m. ET
10 mai 2024 16h15 HE
|
KULR Technology Group, Inc.
NYSE:KULR will hold a conference call on Wednesday, May 15th at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its 1st Qtr. financial results.
Farmer Brothers reports third quarter fiscal 2024 financial results and publishes quarterly shareholder letter
09 mai 2024 16h05 HE
|
Farmer Bros. Co.
Farmer Brothers reports third quarter fiscal 2024 financial results. Records year over year increase in gross margin of 660 basis points to 40.1%.
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
09 mai 2024 16h01 HE
|
MacroGenics, Inc.
Presentation of interim TAMARACK Phase 2 study data: updated safety and preliminary efficacy of vobra duo in mCRPC patientsConference call scheduled for today at 4:30 p.m. ET ROCKVILLE, Md., May 09,...
Research Frontiers Reports First Quarter 2024 Financial Results and Will Host a Conference Call at 5:30p.m. Today
09 mai 2024 16h01 HE
|
Research Frontiers Incorporated
WOODBURY, N.Y., May 09, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2024. Management will host a conference call today at...
Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
09 mai 2024 14h51 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report first...
Caledonia Mining Corporation Plc Notice of Results and Investor Presentation
09 mai 2024 02h00 HE
|
Caledonia Mining Corporation Plc
ST HELIER, Jersey, May 09, 2024 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (NYSE AMERICAN, AIM and VFEX: CMCL) expects to publish its Q1 results for 2024 on...